Stock Taper 
GREAT POINT PARTNERS LLC
Latest 13F filing data - Q2 2026
Holdings
(Top positions)| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
 Enliven Therapeutics, Inc. | ELVN | 70K | $3.55M |
 Nektar Therapeutics | NKTR | 175K | $12.22M |
 Oruka Therapeutics, Inc. | ORKA | 183.33K | $17.45M |
 Abivax S.A. | ABVX | 204.31K | $27.23M |
 Cullinan Therapeutics, Inc. | CGEM | 300K | $5.46M |
 LB Pharmaceuticals Inc Common Stock | LBRX | 317.22K | $10.3M |
 Definium Therapeutics, Inc. | DFTX | 425K | $19.99M |
 Vera Therapeutics, Inc. | VERA | 600.84K | $25.78M |
 Amylyx Pharmaceuticals, Inc. | AMLX | 700K | $12.57M |
 Relmada Therapeutics, Inc. | RLMD | 842.11K | $5.83M |
 MoonLake Immunotherapeutics | MLTX | 855.81K | $16.66M |
 Alumis Inc. | ALMS | 856.06K | $24.09M |
 SCYNEXIS, Inc. | SCYX | 944.29K | $3.84M |
 Altimmune, Inc. | ALT | 1.74M | $5.29M |
 Humacyte, Inc. | HUMA | 3.75M | $2.93M |